Arora Medicine Private Limited
Founded in 2023 and headquartered in Rajasthan, India.
2023 | Jaipur, Rajasthan (India) | Active
Arora Medicine Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 1 Year 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.40 Cr
About Arora Medicine
Arora Medicine Private Limited (AMPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 October 2023 (One year and four months 18 days old ). Its registered office is in Jaipur, Rajasthan, India.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.40 Cr.
Ajay Arora and Vishal Arora serve as directors at the Company.
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U46497RJ2023PTC090523
- Company No.
090523
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Oct 2023
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Who are the key members and board of directors at Arora Medicine?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Arora  | Director | 12-Oct-2023 | Current |
| Vishal Arora | Director | 12-Oct-2023 | Current |
Financial Performance of Arora Medicine.
Enhance accessibility to Arora Medicine's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Arora Medicine?
Unlock access to Arora Medicine's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- C.M. Arora Pharma Private Limited
Ajay Arora and Vishal Arora are mutual person
- Inspeed Formulations Private Limited
Ajay Arora and Vishal Arora are mutual person
Charges (Loans)
Open Charges
₹74.00 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 7.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Feb 2024 | Others | ₹7.40 Cr | Open |
How Many Employees Work at Arora Medicine?
Unlock and access historical data on people associated with Arora Medicine, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arora Medicine, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arora Medicine's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.